Celltrion (XKRX:068270) Inventories, Finished Goods : ₩2,639,487 Mil (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Celltrion Inventories, Finished Goods?

Celltrion's quarterly finished goods increased from Sep. 2023 (₩198,685 Mil) to Dec. 2023 (₩2,727,467 Mil) but then declined from Dec. 2023 (₩2,727,467 Mil) to Mar. 2024 (₩2,639,487 Mil).

Celltrion's annual finished goods increased from Dec. 2021 (₩358,545 Mil) to Dec. 2022 (₩365,107 Mil) and increased from Dec. 2022 (₩365,107 Mil) to Dec. 2023 (₩2,727,467 Mil).

Celltrion Inventories, Finished Goods Historical Data

The historical data trend for Celltrion's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celltrion Inventories, Finished Goods Chart

Celltrion Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

Get a 7-Day Free Trial

184,115.24

194,504.07

358,544.68

365,106.61

2,727,466.92

Celltrion Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Finished Goods	Get a 7-Day Free Trial															187,112.44	179,554.51	198,684.73	2,727,466.92	2,639,487.05

Celltrion Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Celltrion (XKRX:068270) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celltrion Inc (XKRX:068270) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

N/A

Address

13-6 SongDo-Dong, Yeonsu-gu, Incheon City, KOR, 406-840

Website

http://www.celltrion.com

Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.

Celltrion (XKRX:068270) Headlines

No Headlines